Finance

Lists
Why is NCC0 up 2.04%?
Dive Deeper
NCC0:FRA
Pharmather Holdings Ltd
€0.025
+2.04%
(+0.00050) 1D
Oct 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NCC0...
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
5.01M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.10
52-wk low
€0.02
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
5.01M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.10
52-wk low
€0.02
News stories
From web sources and news partners
About Pharmather Holdings Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Websitepharmather.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
150.80K
17.56K
17.20K
-37.42K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169.67K
183.64K
156.22K
120.07K
Operating expense
320.46K
201.19K
173.42K
82.65K
Total operating expenses
320.46K
201.19K
173.42K
82.65K
Operating income
-320.46K
-201.19K
-173.42K
-82.65K
Other non operating income
-14.92K
-9.84K
170.65K
-214.12K
EBT including unusual items
-439.19K
-248.46K
-2.36K
79.58K
EBT excluding unusual items
-339.19K
-215.13K
-2.36K
-296.77K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-439.19K
-248.46K
-2.36K
79.58K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
5.00
6.00
404.00
-
Interest expense
-
-
-
-
Net interest expenses
5.00
6.00
404.00
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps